Loading clinical trials...

Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics | Clinical Trials | Clareo Health

COMPLETEDPHASE2/PHASE3

Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics

NCT01324921•Abbott Nutrition

View on ClinicalTrials.gov

Summary

To compare the postprandial glycemic and insulinemic response of subjects with type 2 diabetes consuming a typical breakfast meal or no breakfast to 10004RF via a meal tolerance test (MTT).

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. type 2 diabetes
•2. between 21 and 75 years of age
•3. male or a non-pregnant, non-lactating female, at least 6 weeks postpartum or postmenopausal or surgically sterile
•4. BMI is \> 18.5 kg/m2 and \<35 kg/m2
•5. If subject is on a chronic medication such as an anti-hypertensive, lipid-lowering, thyroid medication or hormone therapy, they have been on constant dosage for at least two months prior to screening visit.

Exclusion Criteria

•1. Hemoglobin A1c value at screening of greater than or equal to 9%.
•2. Uses exogenous insulin or exenatide for glucose control.
•3. type 1 diabetes.
•4. history of diabetic ketoacidosis.
•5. current infection; has had inpatient surgery, or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks prior to screening visit.
•6. active malignancy
•7. significant cardiovascular event ≤ six months prior to screening visit; or stated history of congestive heart failure.
•8. end-stage organ failure or is status post organ transplant.
•9. history of renal disease.
•10. current hepatic disease.
+6 more criteria

Locations (2)

Provident Clinical Research and Consulting LLC

Glen Ellyn, Illinois, United States

Radiant Research

Cincinnati, Ohio, United States

Key Dates

Start Date

August 1, 2010

Primary Completion Date

September 1, 2010

Completion Date

September 1, 2010

Last Updated

March 30, 2011

Enrollment

ACTUAL participants

Conditions

Diabetes Mellitus, Type 2

Interventions

No breakfast/beverage only

OTHER

Breakfast

OTHER

10004RF

OTHER

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

NCT06959901

Obesity and Diabetes Mellitus, Type 2Diabetes Prevention

View study

RECRUITINGNA

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035

Diabetes Mellitus, Type 2Depressive Symptoms+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 30, 2011Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics

Inclusion Criteria

Exclusion Criteria

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes

Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use

Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)